The new solution for AV fistula creation

The Ellipsys™ Vascular Access System is the surgery-free alternative to AV fistula creation.


  • Fast and efficient – the procedure can be completed in just 30 minutes1

  • Reproducible and minimally invasive1

  • Requires no incision, implant, or suture – innovative percutaneous  AVF technology2

  • Patients leave with a single puncture – no scars, no lumps or bumps, less risk of complications3
  • Minimally invasive
  • Highly effective

The Ellipsys™ System offers:

  • Patented tissue fusion technology, enabling immediate, minimally invasive creation of permanently fused anastomosis4

  • A track record of achievement in over 3,000 procedures in several settings5

Peer-reviewed manuscripts from Germany and France comparing the Ellipsys™ System to surgical AVF creation have demonstrated its effectiveness:6,7

  • There was no difference in secondary patency of endoAVF compared to sAVF through 12 or 24 months6
  • Procedure time with Ellipsys™ System was significantly shorter with endoAVF compared to sAVF7

Hear what the experts say

Watch the video to learn about the EllipsysTM Vascular Access System - presentation by Drs. Alex Mallios and Robert Shahverdyan.

Optimize the care continuum

Learn how to optimize the entire care continuum for endovascular AVF creation including patient selection, fistula creation, maturation, and cannulation.

Doctor patient portrait

Download our patient brochure
to learn more.

additional resources

Explore our vast education offering and register to the sessions of your interest.

With the Ellipsys™ Vascular Access System, we have solutions to support end-stage renal disease patients across the vascular access care continuum.

Complementary AV fistula
maintenance solutions include:


Support for you and your patients

Contact us

† The approved product name for the drug-coated balloon is IN.PACT™ Admiral™ Paclitaxel-coated PTA Balloon Catheter.​



 Hull JE, Jennings WC, Cooper RI, Waheed U, Schaefer ME, Narayan R. The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula​ Creation for Hemodialysis Access. J Vasc Interv Radiol. February 2018;29(2):149-158.e5​.


Frankel A. Temporary Access and Central Venous Catheters. Eur J Vasc Endovasc Surg. April 2006; (31), 417-422​


Mallios A, Bourquelot P, Franco G, et al. Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical​ recommendations, and an algorithm for maintenance. J Vasc Surg. December 2020;72(6):2097-2106.​


Beathard GA, Litchfield T, Jennings WC. Two-year cumulative patency of endovascular arteriovenous fistula. J Vasc Access. May 2020;21(3):350-356.​


Data on file at Medtronic as per claims matrix UC202304488EN - Ellipsys.


Harika et al. Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas. JVS Feb 2021.​


Shahverdyan R et al. Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas. AJKD March 2021.​